TickerFacts.

Emergent BioSolutions Inc. (EBS): Shareholders' Equity

Annual figures by period end, from SEC filings.

$522.60M
As of 2025-12-31
$341.40M
As of 2026-06-30
-27.8%
3-year compound annual growth
-18.5%
5-year compound annual growth
$1.61B2010-12-31: $369.46M2011-12-31: $414.25M2012-12-31: $441.36M2013-12-31: $489.62M2014-12-31: $553.20M2017-12-31: $912.30M2018-12-31: $1.01B2019-12-31: $1.09B2020-12-31: $1.45B2021-12-31: $1.61B2022-12-31: $1.39B2023-12-31: $649.30M2024-12-31: $482.80M2025-12-31: $522.60M$522.60M
2010-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$522.60M+8.2%2026-02-27, Balance as of period end
2024-12-31$482.80M-25.6%2026-02-27, Balance as of period end
2023-12-31$649.30M-53.2%2026-02-27, Balance as of period end
2022-12-31$1.39B-13.9%2025-03-04, Balance as of period end
2021-12-31$1.61B+11.1%2024-03-08, Balance as of period end
2020-12-31$1.45B+33.3%2023-12-11, Balance as of period end
2019-12-31$1.09B+7.7%2022-02-25, Balance as of period end
2018-12-31$1.01B+10.8%2021-02-19, Balance as of period end
2017-12-31$912.30Mn/a2020-02-25, Balance as of period end
No annual figure between 2014-12-31 and 2017-12-31.
2014-12-31$553.20M+13.0%2015-03-09, Balance as of period end
2013-12-31$489.62M+10.9%2015-03-09, Balance as of period end
2012-12-31$441.36M+6.5%2014-03-10, Balance as of period end
2011-12-31$414.25M+12.1%2013-03-08, Balance as of period end
2010-12-31$369.46Mn/a2012-03-09, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Emergent BioSolutions Inc. (EBS)2025-12-31$522.60M+8.2%
Pacira BioSciences, Inc. (PCRX)2025-12-31$693.11M-11.0%
Corcept Therapeutics Inc (CORT)2025-12-31$647.80M-4.7%
Amphastar Pharmaceuticals, Inc. (AMPH)2025-12-31$788.80M+7.7%
Supernus Pharmaceuticals, Inc. (SUPN)2025-12-31$1.06B+2.5%
Collegium Pharmaceutical, Inc (COLL)2025-12-31$301.68M+31.8%
Kiniksa Pharmaceuticals International, plc (KNSA)2025-12-31$567.61M+29.5%
Ultragenyx Pharmaceutical Inc. (RARE)2025-12-31-$80.00Mn/m
Arrowhead Pharmaceuticals, Inc. (ARWR)2025-09-30$503.42M+163.5%

Compare EBS, PCRX, CORT, AMPH side by side · Screen every company in Pharmaceutical Preparations ↗